Meldungen zum Thema Medizin, Gesundheit

Medison Pharma

Sarah Otten Joins Medison Pharma as VP, GM Americas Region

Petach Tikvah, Israel and Zug, Switzerland (ots/PRNewswire) - Sarah Otten will lead Medison's Americas region covering Canada and Latin America. Sarah brings vast geographical expansion experience in international markets. Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets ("Medison"), is proud to announce the joining of Sarah ...

HUMA Therapeutics

Huma to provide best-in-class digital clinical trials solutions through landmark acquisition of Alcedis

London and Frankfurt, Germany (ots/PRNewswire) - - Acquisition combines award-winning digital health platform with global clinical research expertise acquired over 25 years - Creates new and advanced digital solutions across all phases of clinical trials - Accelerates patient recruitment and the development of new ...

Sanisure

Sanisure Announces the Acquisition of a Leading Silicone Extrusion Facility in Twinsburg, Ohio

Camarillo, Calif. (ots/PRNewswire) - Sanisure, a leading, vertically-integrated player in the single- use bioprocessing technology space, is pleased to announce the acquisition of Medical Elastomer Development, Inc ("MED") a silicone extrusion facility from Q Holding, a 3i portfolio company. This state-of-the-art facility located in Twinsburg, Ohio, serves many ...

The Department of Health - Abu Dhabi

AstraZenca, G42 Healthcare enter strategic partnership to manufacture pharmaceutical products in Abu Dhabi

Abu Dhabi, Uae (ots/PRNewswire) - Building on the ongoing efforts of the Department of Health – Abu Dhabi (DoH) in spearheading Abu Dhabi's healthcare ecosystem, AstraZeneca, a science-led biopharmaceutical and one of the top 10 biopharma companies globally, and G42 Healthcare, an AI-powered healthcare company, ...

Finaccord, an Aon company

New Finaccord study reveals dramatic changes in consumer attitudes to travel insurance since COVID-19

London (ots/PRNewswire) - Consumer travel insurance markets have been heavily impacted by the COVID-19 pandemic, with particular disruption to international travel by older travellers. Both take-up rates and the types of policy bought have changed, and consumers are now more aware of the risk posed by pandemics. ...

Hovione

Hovione and GEA announce a strategic collaboration to advance Continuous Tableting

Lisbon, Portugal (ots/PRNewswire) - Hovione and GEA today announced a strategic collaboration to advance Continuous Tableting. This partnership stemmed from a successful customer-supplier relationship spanning several years. It combines GEA´s engineering expertise with Hovione´s development and manufacturing experience and both parties commit to partner to accelerate ...

Menarini-Silicon Biosystems

Circulating Tumor Cell detection by Menarini Group's CELLSEARCH® System leading to genomic profiling of myeloma cells shows potential for non-invasive management of Multiple Myeloma patients at early stages of disease

Huntingdon Valley, Pa. (ots/PRNewswire) - Researchers at Dana-Farber Cancer Institute showed that enumeration of circulating tumor cells (CTCs) with Menarini Silicon Biosystems' CELLSEARCH® System and the CELLSERCH® Circulating Multiple Myeloma Cell (CMMC) Test* can be used to monitor and manage patients with ...

Acousia Therapeutics GmbH

Hearing loss company Acousia Therapeutics completes clinical Phase 1 study with its small molecule

Tübingen, Germany (ots) - Hearing loss company Acousia Therapeutics GmbH announced the successful completion of its ACOU085 clinical Phase 1b study today, following the final visit of the last patient treated with the highest ACOU085 dose. ACOU085 is a proprietary small-molecule drug candidate under clinical ...

News Direct

LectureLinx and PAYCE Announce a Global Expansion Through a Worldwide Exclusive Licensing Agreement to Combine Technologies and Services for the Pharmaceutical Industry

BRANFORD, CONN (ots) - --News Direct-- LectureLinx, a leader in compliance technologies for the pharmaceutical and life science industries, and PAYCE, a leading pharmaceutical technology provider for healthcare professionals (HCPs) and healthcare organizations (HCOs) in Europe, have agreed to an exclusive global ...

REVEAL GENOMICS, S.L.

REVEAL GENOMICS PRESENTS THE LATEST HER2DX® DATA IN HER2+ BREAST CANCER AT SABCS 2022

San Antonio (ots/PRNewswire) - - The HER2DX® risk score predicted long-term survival outcomes in clinically low-risk patients in APT and ATEMPT clinical trials. - The HER2DX® pCR score predicted response to chemotherapy in combination with trastuzumab and pertuzumab in DAPHNe and GOM clinical trials. - HER2DX®️ is the first genomic test in the world specialized in ...

TauRx Pharmaceuticals Ltd

LUCIDITY phase 3 topline data presented at CTAD for HMTM - the only oral anti-Tau therapy in late-stage development

Aberdeen, Scotland and Singapore (ots/PRNewswire) - - Tau aggregation inhibitor, HMTM, is an oral drug with a strong safety profile, having no risk of amyloid related imaging abnormalities - Topline results for the Phase 3 study, LUCIDITY, were shared at the Clinical Trials in Alzheimer's Disease (CTAD) conference ...

Tikun Olam Cannbit

Cannbit-Tikun Olam begins cannabis extracts export from Israel to Europe at the largest commercial quantity to date

Tel Aviv, Israel (ots/PRNewswire) - Cannbit-Tikun Olam Israel(TASE:TKUN), Israel's medical cannabis pioneer, today announced that the first commercial shipment of medical cannabis extracts produced by the company was making its way to Germany. It marks the largest volume of cannabis extracts exported from Israel to ...

News Direct

VectorBuilder Won First Prize in Major Innovation Competition

Chicago, IL (ots) - --News Direct-- VectorBuilder Inc. – a global leader in gene delivery technologies – announced that its R&D and manufacturing center in Guangzhou won championship in the 7th “Chuangke Innovation and Entrepreneurship Global Competition” held in Hangzhou, China. This influential and highly competitive contest is one of the largest in China, covering growth-stage enterprises across all high-tech ...

Valuable 500

ACCORDING TO OPINIUM INSURERS INFLATE TRAVEL COVER COSTS BY £242 FOR DISABLED PEOPLE

London (ots/PRNewswire) - - New research from the Valuable 500 reveals that disabled travellers are paying £242 more than non-disabled travellers for travel insurance - Findings also reveal that a fifth of disabled travellers felt unsafe whilst travelling New research shows that disabled tourists are paying £242 more than non-disabled customers for travel insurance ...

APRIL Group

APRIL signs strategic partnership with KKR for its next phase of growth

Paris and Lyon, France (ots/PRNewswire) - After refocusing its activities around insurance distribution and carrying out an in-depth transformation of its business model since its acquisition by CVC Capital Partners in 2019, enabling the group to return to a high level of performance, the APRIL Group announces that it has signed a long-term strategic partnership with ...

Acousia Therapeutics GmbH

Hearing loss company Acousia Therapeutics to present data for lead candidates ACOU085 & ACOU082 at ARO 2023 MidWinter Meeting February 11–15

Tübingen, Germany (ots) - Acousia Therapeutics GmbH, and its partners from the Translational Hearing Research Group at the Tübingen Hearing Research Center (Department of Otolaryngology, Head and Neck Surgery, University of Tübingen), will present data on its lead candidates — clinical stage ACOU085 and late ...

Eagle Genomics

Eagle Genomics Announces USD 20M First Close; Scale-up Funding to Accelerate the Application of Microbiome Science for Global 'One Health' Innovation

Cambridge, England (ots/PRNewswire) - - Funds to support scale-up, including continued development of AI-augmented knowledge discovery platform, the e[datascientist]™, and continued international expansion - Platform business focused on bridging the current 'translation gap', addressing critical bottlenecks in the ...

Schweizerischer Nationalfonds / Fonds national suisse

Improving the efficacy of antibiotics and curbing resistance

Bern (ots) - New findings from NRP 72, financed by the Swiss National Science Foundation, are helping to curb antibiotic resistance. In the field of new antibiotics, however, structures needed for translating results into practice are lacking. Worldwide, more and more pathogens are becoming resistant to today's antibiotics. As antibiotics lose their efficacy, infections that were once easy to treat can give rise to fatal ...

Schweizerischer Nationalfonds / Fonds national suisse

She wants to know how we talk about dying

LumiraDx

LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c Test

London (ots/PRNewswire) - Now Available in Europe, parts of the Middle East, Asia, Latin America, and Africa - Early customers include GP offices and other community-based healthcare settings - Latest figures, released as part of World Diabetes Day, reveal that 1 in 10 adults are now living with diabetes and nearly ...

TauRx Pharmaceuticals Ltd

TauRx Announces Additional Investment of USD119 million following announcement of Phase 3 LUCIDITY Topline Results

Aberdeen, Scotland and Singapore (ots/PRNewswire) - - Substantial investment of USD119 million achieved by TauRx through a warrants exercise triggered by the announcement of LUCIDITY results in October, supporting HMTM regulatory submissions in UK, US and Canada, and preparation for market availability - Shareholder ...

TauRx Pharmaceuticals Ltd

TauRx Announces Additional Investment of USD119 million following announcement of Phase 3 LUCIDITY Topline Results

Aberdeen, Scotland and Singapore (ots/PRNewswire) - - Substantial investment of USD119 million achieved by TauRx through a warrants exercise triggered by the announcement of LUCIDITY results in October, supporting HMTM regulatory submissions in UK, US and Canada, and preparation for market availability - Shareholder ...

Lotus Pharmaceutical

LOTUS REPORTS ITS BEST QUARTER EVER WITH THE BIGGEST LAUNCH IN ITS HISTORY

Taipei, Taiwan (ots/PRNewswire) - Lotus Pharmaceutical (1795: TT), a multinational pharmaceutical company, today reported its financial results for the third quarter ended 30 September 2022. Third quarter financial highlights: - Third quarter 2022 is the best quarter ever in the Company's history, majorly driven by the successful launch of Lenalidomide in the US – ...

Hallura Ltd.

"Click Chemistry" Concept Inspires BiOLinkMatrix by HALLURA™: the Next Generation of HA Dermal Fillers

Yokneam, Israel (ots/PRNewswire) - Harnessing the 2022 Nobel Prize Awarded Click Chemistry Concept, Hallura's Products Revolutionize the Way Hyaluronic Acid is Crosslinked in Dermal Fillers Hallura Ltd., an Israeli aesthetic medical company, announced today that its proprietary technology named the BiOLinkMatrix ...